These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 16002160)

  • 1. The impact of early administration of low-dose atorvastatin treatment on inflammatory process, in patients with unstable angina and low cholesterol level.
    Tousoulis D; Antoniades C; Katsi V; Bosinakou E; Kotsopoulou M; Tsioufis C; Stefanadis C
    Int J Cardiol; 2006 Apr; 109(1):48-52. PubMed ID: 16002160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of early administration of atorvastatin treatment on thrombotic process in normocholesterolemic patients with unstable angina.
    Tousoulis D; Bosinakou E; Kotsopoulou M; Antoniades C; Katsi V; Stefanadis C
    Int J Cardiol; 2006 Jan; 106(3):333-7. PubMed ID: 16337041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of low dose atorvastatin on inflammatory marker levels in patients with acute coronary syndrome and its potential clinical value.
    Lewandowski M; Kornacewicz-Jach Z; Millo B; Zielonka J; Czechowska M; Kaliszczak R; Płońska E; Goracy J; Kaźmierczak J; Naruszewicz M
    Cardiol J; 2008; 15(4):357-64. PubMed ID: 18698545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-dose atorvastatin enhances the decline in inflammatory markers in patients with acute coronary syndromes in the MIRACL study.
    Kinlay S; Schwartz GG; Olsson AG; Rifai N; Leslie SJ; Sasiela WJ; Szarek M; Libby P; Ganz P;
    Circulation; 2003 Sep; 108(13):1560-6. PubMed ID: 12975259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early initiation of low-dose atorvastatin treatment after an acute ST-elevated myocardial infarction, decreases inflammatory process and prevents endothelial injury and activation.
    Stefanadi E; Tousoulis D; Antoniades C; Katsi V; Bosinakou E; Vavuranakis E; Triantafyllou G; Marinou K; Tsioufis C; Papageorgiou N; Latsios G; Stefanadis C
    Int J Cardiol; 2009 Apr; 133(2):266-8. PubMed ID: 18187214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of atorvastatin during early hospitalization in elderly patients with unstable angina.
    Zhao Z; Geng J; Ge ZM; Wang W; Zhang Y; Kang WQ
    Clin Exp Pharmacol Physiol; 2009 May; 36(5-6):554-8. PubMed ID: 19673939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated ICAM-1 and MCP-1 plasma levels in subjects at high cardiovascular risk are diminished by atorvastatin treatment. Atorvastatin on Inflammatory Markers study: a substudy of Achieve Cholesterol Targets Fast with Atorvastatin Stratified Titration.
    Blanco-Colio LM; Martín-Ventura JL; de Teresa E; Farsang C; Gaw A; Gensini G; Leiter LA; Langer A; Martineau P; Egido J;
    Am Heart J; 2007 May; 153(5):881-8. PubMed ID: 17452168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of atorvastatin on risk of recurrent cardiovascular events after an acute coronary syndrome associated with high soluble CD40 ligand in the Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) Study.
    Kinlay S; Schwartz GG; Olsson AG; Rifai N; Sasiela WJ; Szarek M; Ganz P; Libby P;
    Circulation; 2004 Jul; 110(4):386-91. PubMed ID: 15262833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum profiles of matrix metalloproteinases and their tissue inhibitor in patients with acute coronary syndromes. The effects of short-term atorvastatin administration.
    Tziakas DN; Chalikias GK; Parissis JT; Hatzinikolaou EI; Papadopoulos ED; Tripsiannis GA; Papadopoulou EG; Tentes IK; Karas SM; Chatseras DI
    Int J Cardiol; 2004 Apr; 94(2-3):269-77. PubMed ID: 15093992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The influence of low-dose atorvastatin on lipid levels and endothelial vascular function in patients with significant coronary artery stenosis.
    Kuryata OV; Yegorova YV
    Kardiol Pol; 2006 Jan; 64(1):44-8; discussion 49-50. PubMed ID: 16444629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduction in serum levels of adhesion molecules, interleukin-6 and C-reactive protein following short-term low-dose atorvastatin treatment in patients with non-familial hypercholesterolemia.
    Nawawi H; Osman NS; Yusoff K; Khalid BA
    Horm Metab Res; 2003 Aug; 35(8):479-85. PubMed ID: 12953165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of low-dose atorvastatin on circulating monocyte chemoattractant protein-1 in patients with type 2 diabetes complicated by hyperlipidemia.
    Takebayashi K; Matsumoto S; Wakabayashi S; Inukai Y; Matsutomo R; Aso Y; Inukai T
    Metabolism; 2005 Sep; 54(9):1225-9. PubMed ID: 16125534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences in inflammatory and thrombotic markers between unstable angina and acute myocardial infarction.
    Tousoulis D; Antoniades C; Bosinakou E; Kotsopoulou M; Tsoufis C; Marinou K; Charakida M; Stefanadi E; Vavuranakis M; Latsios G; Stefanadis C
    Int J Cardiol; 2007 Feb; 115(2):203-7. PubMed ID: 16787670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atorvastatin in stable angina patients lowers CCL2 and ICAM1 expression: pleiotropic evidence from plasma mRNA analyses.
    Mirjanic-Azaric B; Rizzo M; Sormaz L; Stojanovic D; Uletilovic S; Sodin-Semrl S; Lakota K; Artenjak A; Marc J; Cerne D
    Clin Biochem; 2013 Oct; 46(15):1526-31. PubMed ID: 23792106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment with ezetimibe plus low-dose atorvastatin compared with higher-dose atorvastatin alone: is sufficient cholesterol-lowering enough to inhibit platelets?
    Piorkowski M; Fischer S; Stellbaum C; Jaster M; Martus P; Morguet AJ; Schultheiss HP; Rauch U
    J Am Coll Cardiol; 2007 Mar; 49(10):1035-42. PubMed ID: 17349882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of withdrawal of statin treatment on proinflammatory response and fibrinolytic activity in humans: an effect independent on cholesterol elevation.
    Lai WT; Lee KT; Chu CS; Voon WC; Yen HW; Tsai LY; Sheu SH
    Int J Cardiol; 2005 Feb; 98(3):459-64. PubMed ID: 15708180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of atorvastatin treatment on lipid profile and adhesion molecule levels in hypercholesterolemic patients: relation to low-density lipoprotein receptor gene polymorphism.
    Bolewski A; Lipiecki J; Plewa R; Burchardt P; Siminiak T
    Cardiology; 2008; 111(2):140-6. PubMed ID: 18376126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrin expression on monocytes and lymphocytes in unstable angina short term effects of atorvastatin.
    Dobreanu M; Dobreanu D; Fodor A; Bacarea A
    Rom J Intern Med; 2007; 45(2):193-9. PubMed ID: 18333374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of atorvastatin on inflammatory and fibrinolytic parameters in patients with chronic kidney disease.
    Goicoechea M; de Vinuesa SG; Lahera V; Cachofeiro V; Gómez-Campderá F; Vega A; Abad S; Luño J
    J Am Soc Nephrol; 2006 Dec; 17(12 Suppl 3):S231-5. PubMed ID: 17130267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomised study to compare the efficacy and safety of isapgol plus atorvastatin versus atorvastatin alone in subjects with hypercholesterolaemia.
    Jayaram S; Prasad HB; Sovani VB; Langade DG; Mane PR
    J Indian Med Assoc; 2007 Mar; 105(3):142-5, 150. PubMed ID: 17824470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.